Sodium‑glucose co-transporter‑2 inhibitors in the treatment of diabetes with heart failure

2022 AHA/ACC/HFSA guideline for the management of heart failure, which is valuable for clinical decision-making, was recently released. This guideline recommended patients with heart failure with type 2 diabetes sodium‑glucose co-transporter‑2 inhibitors for the management of hyperglycemia and to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Bo, Gu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145495/
https://www.ncbi.nlm.nih.gov/pubmed/35624512
http://dx.doi.org/10.1186/s12933-022-01526-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145495/
https://www.ncbi.nlm.nih.gov/pubmed/35624512
http://dx.doi.org/10.1186/s12933-022-01526-4

Ejemplares similares